Art

J-GLOBAL ID：201802252166864072   Reference number：18A1140804

Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report

乾癬性紅皮症の管理のための腫瘍壊死因子αアンタゴニスト療法後の感染性心内膜炎:症例報告【JST・京大機械翻訳】

Author (7)： Mizuno Takuro (Department of Cardiovascular Medicine, Kanazawa Medical University Himi Municipal Hospital, Himi, Japan) ,  Kiyosawa Jun (Department of Cardiovascular Medicine, Kanazawa Medical University Himi Municipal Hospital, Himi, Japan) ,  Fukuda Akihiro (Department of Cardiovascular Medicine, Kanazawa Medical University Himi Municipal Hospital, Himi, Japan) ,  Watanabe Seiji (Department of Dermatology, Kanazawa Medical University Himi Municipal Hospital, Himi, Japan) ,  Kurose Nozomu (Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan) ,  Nojima Takayuki (Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan) ,  Kanda Tsugiyasu (Department of Community Medicine, Kanazawa Medical University Himi Municipal Hospital, Himi, Japan)
Material： Journal of Medical Case Reports (Web)
Volume： 11  Issue： 1  Page： 35  Publication year： 2017 
JST Material Number： U7518A  ISSN： 1752-1947  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Background The introduction of...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1140804&from=J-GLOBAL&jstjournalNo=U7518A") }}

Thesaurus term： patient ,  Autopsy ,  man ,  Bacteria ,  Septicemia ,  *case report ,  *therapy ,  Embolism ,  NMR imaging ,  infarct ,  *psoriasis ,  cerebral infarction ,  *TNF alpha ,  bacterial infection (disease) ,  Microembolism ,  microorganism ,  Thromboembolism ,  cerebrovascular disorder
Semi thesaurus term： インフリキシマブ , 【Automatic Indexing@JST】

Author keywords (3)： TNF-α antagonist ,  Psoriasis erythroderma ,  Bacterial endocarditis

JST classification (2)： Cardiovascular system diseases  (GJ03000C) ,  Infectious diseases,parasitics diseases in general.  (GD01010H)

Reference (14)：

• Expert Opin Biol Ther.; Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis; H Timlin, CO Bingham; 14; 2014; 893-904; 10.1517/14712598.2014.900536; CR1;
• Ann Rheum Dis.; Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance; KL Winthrop, SA Novosad, JW Baddley, L Calabrese, T Chiller; 74; 2015; 2107-16; 10.1136/annrheumdis-2015-207841; CR2;
• J Infect.; Bacteremia in patients receiving TNF-alpha antagonists-a prospective multicenter study; P Loulergue, F Tubach, D Salmon, P Dellamonica, B Taillan, JB Thorel; 16; 2013; 524-8; 10.1016/j.jinf.2013.07.027; CR3;
• N Engl J Med.; Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent; J Keane, S Gershon, RP Wise, E Mirabile-Levens, J Kasznica; 345; 2001; 1098-104; 10.1056/NEJMoa011110; CR4;
• Int J Rheum Dis.; Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review; C Downey; 2015; CR5;

Terms in the title (6)： 乾癬性紅皮症 ,  腫瘍壊死因子α ,  アンタゴニスト ,  療法 ,  感染性心内膜炎 ,  症例報告